Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Black Diamond Therapeutics Inc (NQ: BDTX )

4.955 -0.015 (-0.30%)
Streaming Delayed Price Updated: 10:51 AM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics Inc

< Previous 1 2 3 4 5 Next >
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed slightly higher on Monday, there were a few notable insider trades. 
Via Benzinga
Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics
Tuesday, Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial clinical data from the dose escalation portion of Phase 1 clinical study of BDTX-1535 for non-small cell lung cancer (NSCLC)  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mostly higher on Thursday, there were a few notable insider trades. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! 
Via InvestorPlace
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic
Via Benzinga
Black Diamond Therapeutics Stock is Shooting Higher Today: Here's Why
Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial  
Via Benzinga
Why Shares of Black Diamond Therapeutics Skyrocketed This Week
The company announced positive early-trial news for non-small cell lung cancer. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Via Benzinga
Tesla And Nvidia Lead The Charge As Stocks Surge: Top Trends Of The Day
Via Benzinga
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42.... 
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Black Diamond Therapeutics’ (NASDAQ: BDTX) BDTX-1535 Proves Promising for EGFR Mutated NSCLC and GBM
Black Diamond Therapeutics has announced encouraging initial data from a Phase 1 study of BDTX-1535, an investigational fourth-generation EGFR MasterKey 
Via Spotlight Growth
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.39% to 33,845.82 while the NASDAQ rose 0.55% to 13,408.91. The S&P 500,... 
Via Benzinga
Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
American Rebel (AREB) Stock Jumps on 1-for-25 Reverse Split
American Rebel (AREB) stock is a hot topic among traders on Tuesday after the self-defense company underwent a reverse stock split. 
Via InvestorPlace
Why Is Black Diamond Therapeutics (BDTX) Stock Up 82%?
Black Diamond Therapeutics (BDTX) stock is seeing massive gains on Tuesday after releasing data from a Phase 1 clinical study. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
From Black Diamond Therapeutics, Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.